Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Equities

Equities

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Equities
  • Global
  • Legal
  • Management
  • Markets
  • News

Boeing’s CEO David Calhoun To Face US Senators’ Questions On Plane Safety Amid Ongoing Investigations

By Benzinga Neuro
June 18, 1:42 AM
Boeing Co.'s CEO, David Calhoun, is set to appear before U.S. senators on Tuesday, where he will be questioned about the company's safety measures amid ongoing investigations.

BA

Read More
2 minute read
  • Equities
  • Global
  • Legal
  • Markets
  • News

Exxon Mobil’s Lawsuit Against Climate Activist Shareholder Arjuna Capital Dismissed By Federal Judge

By Benzinga Neuro
June 18, 12:55 AM
A federal judge has dismissed Exxon Mobil Corp's lawsuit against activist shareholder Arjuna Capital over a climate proposal.

IYE

Read More
3 minute read
  • Equities
  • Global
  • Markets
  • News
  • Tech

Google’s DeepMind Shifting From Research Powerhouse To AI Product Giant, Redefining Industry Dynamics

By Benzinga Neuro
June 18, 12:10 AM
Google DeepMind has decided to transition from a research lab to an AI product factory. This move could potentially challenge the company's long-standing dominance in foundational research.

GOOG

Read More
2 minute read
  • Equities
  • ETFs
  • Markets
  • News

Cathie Wood-Led Ark Picks Up $5.3M Worth Of TSMC Shares— Also Picks Up Palantir, Amazon Stock Amid Ongoing AI Frenzy

By Benzinga Neuro
June 17, 11:55 PM
On Monday, Cathie Wood-led Ark Invest made some significant trades, with Palantir Technologies Inc. (NYSE:PLTR), Taiwan Semiconductor Manufacturing…

AMZN

Read More
2 minute read
  • Equities
  • General
  • Markets
  • News

Palantir, Mustang Bio, DraftKings, Micron, Tesla: Why These 5 Stocks Are On Investors’ Radars Today

By Benzinga Neuro
June 17, 11:12 PM
On Monday, major U.S. indices saw gains, with the Dow Jones Industrial Average closing nearly 0.5% higher at 38,778.10.

DKNG

Read More
2 minute read
  • Analyst Ratings
  • Equities
  • Global
  • Markets
  • News
  • Tech

Apple ‘May Be The Best Of All The Magnificent Seven From Now To Year-End,’ Says Tech Investor Dan Niles

By Benzinga Neuro
June 17, 10:16 PM
Renowned tech investor Dan Niles has made a bullish prediction for Apple Inc, foreseeing the company's ascent to the top of the 'Magnificent Seven' by the year's end.

AAPL

Read More
1 minute read
  • Biotech
  • Equities
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?

By Vandana Singh
June 17, 1:22 PM
BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

BNTX

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Legal
  • Media
  • Movers
  • News
  • Trading Ideas

Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims

By Vandana Singh
June 17, 1:13 PM
Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.

PFE

Read More
2 minute read
  • Equities
  • General
  • Legal
  • Media
  • News

Tesla Sues Former Supplier Over Trade Secret Theft, Seeks $1B Compensation: Report

By Shivani Kumaresan
June 17, 1:09 PM
In a significant legal move, Tesla Inc. is reportedly suing Matthews International, claiming the company misappropriated Tesla's proprietary dry electrode battery technology to the detriment of Tesla's competitive edge and innovation.

FDIS

Read More
1 minute read
  • Equities
  • General
  • Management
  • Movers
  • News

Why Xponential Fitness Shares Are Surging On Monday

By Shivani Kumaresan
June 17, 12:29 PM
Xponential Fitness announces Mark King as the new CEO effective June 17, 2024, boosting investor confidence. King, with a robust track record at Taco Bell and Adidas, aims to enhance global brand performance and franchise operations.

ADDYY

Posts pagination

Previous 1 … 9 10 11 … 1,061 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service